Study to Evaluate the Safety and Preliminary Efficacy of CLL1 and CD38 Dual CAR-T in r/r AML
Status:
Recruiting
Trial end date:
2026-10-01
Target enrollment:
Participant gender:
Summary
This study is a single-center clinical study. The main purpose is an IIT clinical trial to
evaluate the safety and preliminary efficacy of CLL1 and CD38 dual CAR-T injection in r/r AML
subjects . The included population were patients with relapsed and refractory acute myeloid
leukemia (r/r AML) .
Phase:
Early Phase 1
Details
Lead Sponsor:
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China